We investigated whether oral tetrahydrobiopterin (BH 4 ) treatment might slow the progression of atherosclerosis using hypercholesterolemic ApoE-knockout (KO) mice. We report that ingesting BH 4 in drinking water is effective to inhibit atherogenesis in mice. Furthermore, we report that BH 4 treatment improves endothelial dysfunction and attenuates increased mRNA expression of NADPH oxidase components, as well as a number of inflammatory factors, such as LOX-1 and MCP-1, in the aortas of ApoE-KO mice. Strategies such as oral administration of BH 4 to ensure continuous BH 4 availability may be effective in restoring NO-mediated endothelial function and limiting vascular disease and the progression of atherosclerosis.
Introduction
In hypercholesterolemic ApoE-knockout (ApoE-KO) mice, endothelium-dependent vascular relaxation is impaired, NO synthesis is reduced, and vascular superoxide production is increased (1, 2) . Transgenic over-expression of eNOS in ApoE-KO mice surprisingly results in enhanced vascular superoxide production, reduced NO bioavailability, and accelerated atherosclerosis (3) . BH 4 levels are reduced in the aortas of these mice compared with wild-type controls, but dietary BH 4 supplementation reduces superoxide production and increases NO synthesis. Furthermore, transgenic over-expression of GTP-cyclohydrolase I (GTPCH), the rate-limiting enzyme of de novo BH 4 synthesis, in ApoE-KO mice attenuates endothelial dysfunction and atherosclerosis (4) . In this model, endothelial cell BH 4 levels are specifically increased without elevation of plasma BH 4 levels. These results suggest that increased eNOS protein alone is insufficient to maintain NO synthesis in the setting of hypercholesterolemia, and that adequate BH 4 levels are essential to prevent eNOS uncoupling where endothelial dysfunction exists.
Several pharmacologic studies suggest a possible role for BH 4 availability in regulating NO-mediated endothelial function. Shinozaki et al have shown that oral administration of BH 4 prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats (5) . In addition, we have shown that supplementation with BH 4 prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress in rats (6) . Thus, BH 4 may not only improve NO-mediated endothelial function but may also reduce vascular oxidative and nitrosative stress, thereby potentially reducing the development of atherosclerosis. Since the long-term effects of BH 4 supplementation on the development of vascular disease remain uncertain, we sought to investigate the effects of oral administration of BH 4 on the development of atherosclerosis in ApoE-KO mice.
Material and Methods

Animals
ApoE-KO mice (n = 40) were weaned at 5 weeks of age onto a high-cholesterol diet (1.25% cholesterol, 7.5% cocoa butter, 7.5% casein, 0.5% sodium cholate; Oriental Yeast Co., Tokyo, Japan) and maintained on the diet for 10 weeks. Half of the ApoE-KO mice (ApoE-KO/BH 4 mice, n = 20) were maintained on the high-cholesterol diet supplemented with 10 mg/kg/day BH 4 in drinking water as described previously (6) .
Wild-type (WT: C57B/6J) mice were used to provide a control group in some experiments (n = 12). Animals were provided their diet and water ad libitum and maintained on a 12-hour light/dark cycle. All animal experiments were conducted according to the Guidelines for Animal Experiments at Dokkyo University School of Medicine.
Assessment of atherosclerosis
The extent of atherosclerosis was determined macroscopically upon opening the aortas and by examination of serial sections from the aortic roots. Each aorta was cut open longitudinally and pinned flat onto a silicone-coated dissecting dish and stained with oil red O solution (0.3% in isopropyl alcohol diluted with water, 3:2 vol/vol). Excess stain was washed off with 60% isopropyl alcohol. Images were captured with an Olympus digital camera mounted on an Olympus SZX9 dissecting microscope.
The aortic root samples were cut into 10 µm sections. Five consecutive sections were selected using 120 µm intervals for each mouse and were stained with oil red O solution (0.03% in isopropyl alcohol diluted with water, 3:2 vol/vol) for 15 minutes and washed with 60% isopropyl alcohol. Images were captured with an Olympus BX417 microscope and an Olympus digital camera. The lipid-stained areas were analyzed with Adobe Photoshop 7 software and MacSCOPE software.
Organ chamber experiments
Organ chamber experiments were performed as previously described (6) . The aortic rings were exposed to acetylcholine (Ach) in order to assess endothelial vasodilation. Endothelium-independent relaxation as a result of exposure to sodium nitroprusside (SNP) was also examined.
Measurement of vascular superoxide anion production
Superoxide anion production was measured using lucigenin chemiluminescence, as previously described (6) . Lucigenin counts were expressed as counts per minute per milligram of dry weight. Measurements were also performed in the presence of apocynin (100 µmol/L), a NAD(P)H oxidase inhibitor, which inhibits the assembly of NADPH oxidase (7).
Assay of biopterin in aorta
Concentration of total biopterin (BH 4 and more oxidized species) was measured as described by Fukushima and Nixon (8) .
Real-Time PCR
For quantitative measurement of mRNA, 2 mg of total RNA were treated with DNase I for 15 min and subsequently used for cDNA synthesis. PCR reactions with cDNA were carried out in a LineGene system (BioFlux, Tokyo, Japan).
Statistical analysis
Data were expressed as mean ± SD. An unpaired Student's t test was used to detect significant differences whenever two groups were compared. One-way ANOVA was used to compare differences among three or four groups, with Bonferroni's test for post hoc analysis. P values less than 0.05 were considered statistically significant.
Results
Plasma lipids levels
Plasma cholesterol levels were markedly elevated by ingestion of a high cholesterol diet in ApoE-KO (2512 ± 278 mg/dl) and ApoE-KO/BH 4 mice (2537 ± 128 mg/dl), and significant differences between the two groups were not observed. In contrast, triglyceride levels were not affected by the high cholesterol diet in either group.
Aortic Biopterin Levels
We first determined whether BH 4 treatment might lead to increased BH 4 levels by measuring biopterin levels in homogenates of snap-frozen aorta. Total biopterin levels were significantly greater in the ApoE-KO/BH 4 group, compared with the ApoE-KO group (Figure 1) , as a result of oral ingestion of BH 4 . In ApoE-KO/BH 4 mice, the biopterin level was 125% that observed in ApoE-KO mice.
Effect of BH 4 on Endothelial Function
Endothelium-dependent relaxation due to acetylcholine (ACh), a receptor-mediated eNOS agonist, was significantly impaired in ApoE-KO mice, compared with ApoE-KO/BH 4 mice (Figure 2A ). In fact, endothelium-dependent relaxation was not significantly impaired in ApoE-KO/BH 4 mice, compared to control WT mice fed a high-fat diet (data not shown). Endothelium-independent relaxation in response to the NO donor sodium nitroprusside was identical in both groups, demonstrating no differences in vascular smooth muscle responses to NO ( Figure 2B ). These observations indicate that increased endothelial BH 4 levels preserve NO-mediated endothelial function in the setting of atherosclerosis.
Atherosclerotic Lesion Formation
The development of atherosclerosis was assessed by measuring lipid-stained areas within the aortas and aortic root sections. After ingestion of a Western-type diet for 10 weeks, atherosclerotic lesions were evident in the aortas of ApoE-KO mice and ApoE-KO/BH 4 mice, whereas control C57Bl/6J mice were almost free of detectable lesions. Representative photographs of oil red O aortic staining are shown in Figure 3A . Lipidstained areas were primarily observed at the aortic curvature and branching points of other vessels. Significantly fewer lipid-stained areas were observed in the aortic sinuses of ApoE-KO/BH 4 mice, compared with ApoE-KO mice (41.2 ± 1.4 vs 52.3 ± 2.6 %; Figure 3A ).
Five consecutive sections surrounding the root of the aortic valve were taken from each mouse and stained with oil red O to assess lesion formation in that region. Representative sections are shown in Figure  3B . After 10 weeks of a high cholesterol diet, a significant reduction in plaque area was observed within aortic root sections from ApoE-KO/BH 4 mice, compared to ApoE-KO mice. The mean aortic root plaque area was reduced by 25% in ApoE/BH 4 mice, compared with ApoE-KO mice ( Figure 3B) .
Thus, ApoE-KO/BH 4 mice demonstrated reduced lesion size and thickness, compared with ApoE-KO mice. Thus, BH 4 administration slows the progression of atherosclerosis in the setting of hypercholesterolemia.
Superoxide production in the aorta
A small amount of superoxide production was noted in the aortas of WT mice. Markedly increased aortic superoxide production was observed in ApoE-KO mice (Figure 4) . Importantly, BH 4 treatment significantly suppressed superoxide production within the aorta (Figure 4 ). An NADPH oxidase inhibitor, apocynin, markedly inhibited endothelial superoxide production in ApoE-KO and ApoE-KO/BH 4 mice ( Figure  4 ). Endothelial denudation normalized superoxide production in ApoE-KO and ApoE-KO/BH 4 mice with a remaining production of superoxide anions in vascular smooth muscle cells. Incubation of aortic sections with 1 mmol/L L-NAME to inhibit eNOS decreased endothelial superoxide production in ApoE-KO aortas, suggesting that in these mice eNOS uncoupling contributed to a net generation of superoxide (data not shown). 
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Endothelium-independent vessel relaxation in response to the NO donor sodium nitroprusside was identical in both groups of mice.
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Fi g. 3 . Aortic mRNA expression levels for eNOS, iNOS, gp91, p47, p67, CZ-SOD, ICAM, VCAM, LOX-1, and MCP-1 in WT, ApoE-KO, and ApoE-KO/BH4 mice by RealTime PCR. Data represent the means ± SD of at least three independent experiments, and are expressed as a ratio of GAPDH. *P < 0.05, **P < 0.01 compared with WT mice, and #P<0.05 compared with ApoE-KO mice.
mRNA levels of inflammatory mediators in aortic tissue eNOS mRNA levels were greater in ApoE-KO mice, compared with WT or ApoE-KO/BH 4 mice. iNOS mRNA levels were barely detectable in WT mice, while they were clearly increased in ApoE-KO mice, and decreased by treatment with BH 4 (ApoE-KO/BH 4 ) ( Figure 5 ). The mRNA levels of various components of the NADPH oxidase system, including gp91, p47, and p67, were markedly increased in ApoE-KO mice, compared with WT mice, which was significantly attenuated by treatment with BH 4 (ApoE-KO/BH 4 ). mRNA levels of CZ-SOD were increased in ApoE-KO and ApoE-KO/BH 4 mice, however, this was not a significant finding. mRNA levels of ICAM and VCAM were clearly increased in ApoE-KO mice, compared with WT mice, and decreased by treatment with BH 4 (ApoE-KO/BH 4 ). LOX-1 and MCP-1 mRNA levels were increased in ApoE-KO mice, compared with WT mice, and significantly reduced by treatment with BH 4 (ApoE-KO/BH 4 ) ( Figure 5 ).
Discussion
In this study, we investigated whether oral treatment with BH 4 might reduce the progression of atherosclerosis in hypercholesterolemic ApoE-KO mice. Although oral administration of BH 4 has been reported to prevent endothelial dysfunction and vascular oxidative stress in various rat models (5, 6) , it remains unclear whether oral BH 4 treatment might actually inhibit atherogenesis. We report that ingesting BH 4 in drinking water slows the progression of atherosclerosis in mice. Furthermore, we report that BH 4 treatment improves endothelial dysfunction and attenuates increased mRNA expression of various components of the NADPH oxidase system, as well inflammatory mediators, such as LOX-1 and MCP-1, in the aortas of ApoE-KO mice. These results suggest that BH 4 is a rational therapy to ameliorate endothelial dysfunction and prevent atherosclerosis in the setting of factors such as hypercholesterolemia.
Oral BH 4 treatment may have non-specific antioxidant effects. However, these appear beneficial, and a number of antioxidant effects, including reduction of NADPH oxidase expression, may be partly responsible for attenuation of endothelial dysfunction and inflammatory gene expression. We previously reported that oral BH 4 administration restores decreased adiponectin levels in angiotensin II-treated rats by exerting antioxidant effects on adipocytes (9) . Adiponectin is an adipocyte-derived cytokine that has anti-diabetic and anti-atherogenic effects. Thus, BH 4 has beneficial effects on NO-mediated, as well as functions not mediated by NO, within the vasculature and elsewhere in the body. In this study, mice ingested BH 4 in drinking water, in which BH 4 is remarkably stable. We found that 85% of BH 4 remained intact in drinking water shaded from light after 24 h, while 100% remained intact in the presence of ascorbate (0.04%). Since we changed the drinking water every day, we estimate ingestion of ∼85% of the total amount of BH 4 added to drinking water and therefore adjusted the BH 4 concentration to ensure ingestion of 10 mg/kg/day in accordance with the total water intake of the mice.
In conclusion, the present study demonstrates that oral administration of BH 4 reduces atherosclerosis in experimental ApoE-KO mice. Oral administration of BH 4 appears to be safe in humans, thus, further research is required to establish the potential of oral BH 4 treatment for prevention of endothelial dysfunction and protection against the development of cardiovascular disease and atherosclerosis in humans.
